Shudong Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shudong Lin has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hongye Pan
Jiangxi Conba Traditional Chinese Medicine Co.,Ltd, Shangrao 334400, China
1 shared publication - Houfa Yin
Zhejiang University, Eye Center of Second Affiliated Hospital, School of Medicine, Hangzhou, China
1 shared publication - Huihui Jin
Zhejiang Conba Pharmaceutical Co.,Ltd, Hangzhou 310051, China
1 shared publication - Jing Xu
Jiangxi Conba Traditional Chinese Medicine Co.,Ltd, Shangrao 334400, China
1 shared publication - Jiong Chen
Laboratory of Biochemistry and Molecular Biology, School of Marine Sciences, Ningbo University
1 shared publication - Jiwei Zhang
The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication
Latest Publications
- 20 October 2027
- Published by ACG Publications in Records of Natural Products
- Vol. 21 (2)
Integrated multi-omics reveals the multidimensional mechanisms of Niuhuang Shangqing capsule against internal excess-heat pattern constipation
Niuhuang Shangqing Capsule (NHSQC) is a classical heat-pattern-related multi-herb traditional Chinese medicine formula. This study investigated its therapeutic effects and mechanisms in a mouse model of internal excess-heat pattern constipation using integrated metabolomics and gut microbiota multi-omics. Ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) putatively annotated 201 compounds in NHSQC. A constipation model was established by combined administration of a hot-nature herbal extract and loperamide. NHSQC treatment significantly shortened the time to first black stool, increased fecal water content, and enhanced small intestinal transit rate. It upregulated colonic tight junction protein expression, improved serum gastrointestinal hormone profiles, increased goblet cell numbers, and reduced levels of inflammatory cytokines (IL-1, TNF-, IL-6). Furthermore, NHSQC modulated gut microbiota composition, altered fecal metabolite profiles, and preliminarily indicated the involvement of the FoxO signaling pathway in its protective effects. These findings provide pre-clinical evidence that NHSQC alleviates internal excess-heat pattern constipation through a multi-dimensional regulatory network involving multiple components, molecular targets, gut microbiota, and metabolic signaling including the FoxO pathway to restore intestinal function.
- 20 October 2027
- Published by ACG Publications in Records of Natural Products
- Vol. 21 (2)
Integrated multi-omics reveals the multidimensional mechanisms of Niuhuang Shangqing capsule against internal excess-heat pattern constipation
Niuhuang Shangqing Capsule (NHSQC) is a classical heat-pattern-related multi-herb traditional Chinese medicine formula. This study investigated its therapeutic effects and mechanisms in a mouse model of internal excess-heat pattern constipation using integrated metabolomics and gut microbiota multi-omics. Ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) putatively annotated 201 compounds in NHSQC. A constipation model was established by combined administration of a hot-nature herbal extract and loperamide. NHSQC treatment significantly shortened the time to first black stool, increased fecal water content, and enhanced small intestinal transit rate. It upregulated colonic tight junction protein expression, improved serum gastrointestinal hormone profiles, increased goblet cell numbers, and reduced levels of inflammatory cytokines (IL-1, TNF-, IL-6). Furthermore, NHSQC modulated gut microbiota composition, altered fecal metabolite profiles, and preliminarily indicated the involvement of the FoxO signaling pathway in its protective effects. These findings provide pre-clinical evidence that NHSQC alleviates internal excess-heat pattern constipation through a multi-dimensional regulatory network involving multiple components, molecular targets, gut microbiota, and metabolic signaling including the FoxO pathway to restore intestinal function.
- 10 August 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2993-3011
LECT2–RPS27A interaction involving Lys48 attenuates neuroinflammation in diabetic retinopathy
- 10 August 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2993-3011
LECT2–RPS27A interaction involving Lys48 attenuates neuroinflammation in diabetic retinopathy